{
  "trial_id": "NCT03283813",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "both sexes",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "between 6 and 18 years of age",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "obese, according to the IOTF criteria (Cole TJ et al., 2000)",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "pubertal stage \u2265 3 according to the Tanner stage (Tanner et al., 1961)",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "HOMA-IR > 2,5 or insulin > 15 \u00b5U/ml",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Serum Zinc level in the range of normality or under the normal levels.",
      "label": "met",
      "evidence": ""
    }
  ],
  "exclusion": [
    {
      "criterion": "Adverse reactions to the product or component of the product (allergies\u2026)",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Genetic obesity (Prader Willi syndrome, Down syndrome), Metabolic obesity",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Chronic diseases, hepatic or gastroenterological diseases",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Medical treatment for chronic diseases",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Supplementation with inositol-like products or supplements containing Zinc and Inositol.",
      "label": "met",
      "evidence": ""
    }
  ],
  "notes": "The patient has Hashimoto's thyroiditis, but her symptoms improved significantly after starting Levothyroxine. She is still overweight.",
  "_meta": {
    "topic_id": "30",
    "trial_id": "NCT03283813",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}